[Antirheumatics with fibrinolytic properties. Comparison between compounds of the flufenamic acid series with trifluoromethyl analogues of azapropazone].
D000700:Analgesics / Q000494:pharmacology*; D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D004123:Dimethylamines / Q000494:pharmacology; D004487:Edema; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D005439:Flufenamic Acid / Q000494:pharmacology; D006845:Hydrocarbons, Fluorinated / Q000494:pharmacology; D008314:Malonates / Q000494:pharmacology; D009539:Nicotinic Acids / Q000494:pharmacology*; D051381:Rats; D013329:Structure-Activity Relationship; D014227:Triazines / Q000494:pharmacology*
D000700:Analgesics; D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D004123:Dimethylamines; D005343:Fibrinolytic Agents; D006845:Hydrocarbons, Fluorinated; D008314:Malonates; D009539:Nicotinic Acids; D014227:Triazines; D005439:Flufenamic Acid
Fibrinolytische Antirheumatika. Vergleich von Substanzen der Flufenamsäure-Reihe mit Trifluormethyl-Analogen des Azapropazons.